(MENAFN) UAE's Julphar registered USD381.1 million revenue in 2014, marking a 5.2 percent increase compared to 2013, Arabian Business reported.
The largest Emirati pharmaceutical company said that sales were motivated by the private market sales which witnessed a 7.5 percent growth with net profit hitting USD63.88 million.
Operational performance also went up with gross profit hitting USD230.86 million, marking a 3.4 percent increase. operating profit reached USD64.91 million.
"2014 was another year of great achievements for Julphar. We are pleased to close the year at USD381.05 million, which shows a remarkable effort from our global sales," Julphar's CEO said in a statement.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.